Navigation Links
New transplant research from NY-Presbyterian/Weill Cornell
Date:4/29/2011

NEW YORK (April 29, 2011) -- Available for expert commentary on the latest research findings presented at the 2011 American Transplant Congress (ATC) in Philadelphia, April 30 to May 4, is Dr. Sandip Kapur, chief of transplant surgery and director of kidney and pancreas transplant programs at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, and a leading authority on transplantation.

The following are some notable research studies by Dr. Kapur and colleagues being presented at the meeting:

  • Excellent Outcomes Shown for Pancreas Transplantation in Older Patients

    Due to improvements in the management of diabetes, there are an increasing number of older candidates for pancreas transplantation. Recent studies have been equivocal about outcomes for older patients, but, on the positive side, none have shown an increase in acute rejection or complication rates. In their retrospective review, Dr. Kapur and his co-investigators found that pancreas transplantation in older patients is safe and feasible, with excellent graft and patient outcomes. They report that with proper patient selection, older patients can safely receive a pancreas transplant without an increased risk of complications, infections requiring hospitalization, or cytomegalovirus (CMV) infections. Furthermore, these patients also benefit from a lower rejection rate over the lifespan of the transplant.

    Concurrent Session 19: Pancreas Transplantation: Clinical Management and Complications. Sunday, May 1, 2011, 4:12 p.m. Room 113 B.

  • Excellent Outcomes for Pancreas Transplantation in Underweight and Obese Patients

    Pancreas transplantation remains an important option for patients with Type 1 diabetes. Given the metabolic problems associated with diabetes, pancreas transplant candidates may struggle to maintain a healthy body mass index (BMI). As a result, extreme BMIs are sometimes encountered with this condition. Dr. Kapur and his co-investigators report their experience of pancreas transplantation outcomes according to BMI categories. They found that underweight and obese patients have excellent outcomes after pancreas transplantation. With careful selection, these patients should not have an increased risk of postoperative or infectious complications. Furthermore, extremes of BMI do not limit transplant success or patient survival.

    Poster Session: Pancreas Transplant: All Topics. Monday, May 2, 2011, 5:30 p.m. Hall B.

  • Improved Recovery for Kidney Donors Undergoing Laparoendoscopic Single-Site Donor Nephrectomy (LESS-DN) Compared With Laparoscopic Donor Nephrectomy (LDN)

    Laparoscopic donor nephrectomy (LDN) has become the standard of care for kidney retrieval at high-volume transplant centers. Recently, laparoendoscopic single-site donor nephrectomy (LESS-DN) has emerged with the potential benefits of improved cosmesis and convalescence, and decreased morbidity. In the LESS-DN procedure, a natural orifice (the umbilicus or belly button) is used as the single incision site through which the entire donor nephrectomy is performed. Dr. Kapur, along with NewYork-Presbyterian/Weill Cornell surgeon Dr. Joseph Del Pizzo and their co-investigators, describe their experience with 100 consecutive patients undergoing LESS-DN. They report that patients undergoing LESS-DN benefitted from improved donor recovery outcomes and smaller incisions compared with LDN, despite longer operative times.

    Concurrent Session 49: Surgical and Utilization Issues. Monday, May 2, 2011, 4 p.m. Room 108 AB.


'/>"/>

Contact: Linda Kamateh
lib9027@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

Related medicine news :

1. Flu Vaccine Appears Safe After Kidney Transplant
2. Liver-cell transplants show promise in reversing genetic disease affecting liver and lungs
3. Enhanced cord blood stem cell transplants safe in long-term studies
4. Kidney Transplant Patients at Risk of Narrowed Arteries
5. Toronto XVIV0 Lung Perfusion System allows high-risk lungs to be safely transplanted
6. Scarring of Transplanted Kidneys Less of a Problem Today
7. Long-term study shows that kidney transplants are faring better than previously reported
8. More organs for transplant when icu docs help take care of brain dead donors, says UPMC
9. Quitting Smoking Cuts Cancer Risk After Liver Transplant
10. Smoking in combination with immunosuppression poses greater risk for transplant-related carcinoma
11. First for Emory -- Rare hand transplant surgery successfully performed at Emory University Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... Leading pediatric oncology experts at Children’s National Health System ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of ...
(Date:10/12/2017)... RAPIDS, Mich. (PRWEB) , ... October 12, 2017 ... ... Wellness, has been named one of Michigan’s 2017 Best and Brightest in Wellness® ... and Brightest in Wellness® awards program on Friday, Oct. 20 from 7:30 a.m. ...
(Date:10/12/2017)... BALTIMORE (PRWEB) , ... October 12, 2017 , ... ... average of $3,296 in property taxes a year. In some states—like New York, ... higher. , By contrast, many overseas retirement havens have extremely low property-tax rates, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... University of California Berkeley, and other leading institutions in announcing the launch of ... institutions to change the way animals are raised for food. , Founding members ...
(Date:10/12/2017)... ... October 12, 2017 , ... Nvision Biomedical Technologies ... with the addition of industry sales leader, Thomas (Tom) Slott, as Senior Vice ... distribution and sales network, direct the efforts of the surgical sales teams, manage ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... Sept. 22, 2017 Janssen Biotech, Inc. (Janssen) ... letter from the U.S. Food and Drug Administration (FDA) ... sirukumab for the treatment of moderately to severely active ... clinical data are needed to further evaluate the safety ... active RA. ...
(Date:9/19/2017)... --  ZirMed Inc ., a recognized leader in cloud-based revenue ... been ranked #1 by its users for the seventh consecutive ... Survey. ZirMed was recognized as the top-ranked end-to-end revenue cycle ... over 200 beds and holds one of the longest #1 ... ...
(Date:9/12/2017)... 12, 2017   EcoVadis , the leading platform for environmental, social ... annual edition of its Global CSR Risk and Performance Index. The report ... based on Scorecard Ratings that analyzed nearly 800,000 data points across the ... ... ...
Breaking Medicine Technology: